查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566798

黏合劑屏障市場：按類型、應用和最終用戶分類：2024-2033 年全球機會分析和產業預測

Adhesion Barrier Market By Type , By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年，黏合阻隔市場估值為7億美元，預計2024年至2033年複合年成長率為7.8%，到2033年達到15億美元。

沾黏屏障是醫療植入，可降低手術期間沾黏形成的風險。沾黏是手術後可能發生的組織和器官之間的異常連接。與沾黏相關的其他併發症包括腸阻塞、不孕症和慢性疼痛，這些併發症可能是由於癒合過程中組織相互沾黏引起的。為了防止粘連，粘連屏障在組織之間形成臨時屏障。

全球黏連屏障市場的成長是由術後沾黏風險的驚人上升所推動的。根據一項研究，93% 的人在一次或多次腹部手術後會出現沾黏。此外，醫療保健專業人員對沾黏相關併發症的認知不斷提高，以及創新黏連屏障產品的開拓也為全球市場的成長做出了重大貢獻。研究人員和製造商正致力於開發由生物可吸收材料製成的黏合屏障，這些材料會逐漸被人體吸收，消除磨損程序。例如，領先的醫療解決方案供應商之一 Baxter AdvancedSurgery 開發了 Seprafilm 黏合屏障。此黏合屏障是一種無菌、可生物吸收、半透明、親水性黏合屏障，由兩種陰離子多醣、改質透明質酸鈉和羧甲基纖維素組成。這種沾黏屏障可以顯著降低沾黏的程度、發生率和嚴重程度。一項隨機、前瞻性、雙盲、多中心臨床研究納入了 183 名患有潰瘍性大腸炎和息肉病的患者，他們接受了兩階段腸切除手術。其中，Seprafilm 沾黏屏障組中有 51% 的患者在術後 8 至 12 週內沒有出現沾黏，而對照組則為 6%。此外，涉及黏合屏障的外科手術報銷政策的增加正在推動其使用並促進全球市場的成長。然而，儘管正在進行研究，但還沒有廣泛用於預防術後沾黏的特定防沾黏屏障，這是市場的主要阻礙因素。相反，醫療保健專業人員正在將粘連屏障納入手術方案中，以盡量減少粘連相關併發症的風險，預計這將成為全球需求的驅動力。此外，醫學協會和醫療組織擴大舉措來傳播意識並建立有關粘連預防和管理的指南，預計將為預測期內全球市場的擴張提供利潤豐厚的機會。

全球黏合屏障市場按類型、應用、最終用戶和地區細分。按類型分類，市場分為合成黏合屏障和天然黏合屏障。依用途分為普通/腹部外科、婦科外科、心血管外科、整形外科、神經外科等。依最終用戶分類，可分為醫院、專科診所和門診手術中心。按地區分類，分析涵蓋北美、歐洲、亞太地區和拉丁美洲/中東/非洲。

主要發現

  • 按產品類型分類，合成黏合屏障細分市場將在 2023 年佔據市場。
  • 根據申請，2023年一般外科/腹部外科業務成為主要股東。
  • 按最終用戶分類，醫院細分市場將在 2023 年獲得最大佔有率。
  • 北美佔有很大佔有率。

競爭格局

該報告可以客製化（需要額外的費用和時間表）。

  • 按產品/細分市場細分
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 平均銷售價格分析/價格分佈分析
  • 擴大公司簡介列表
  • 歷史市場資料

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 關鍵投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章黏合劑屏障市場：按類型

  • 市場概況
  • 合成黏合屏障
  • 天然黏合屏障

第5章黏合劑屏障市場：依應用分類

  • 市場概況
  • 普通外科/腹部外科
  • 婦科手術
  • 心血管外科
  • 整形外科
  • 神經外科
  • 其他

第6章 黏合劑屏障市場：依最終用戶分類

  • 市場概況
  • 醫院
  • 專科診所
  • 門診手術中心

第7章黏合劑屏障市場：按地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國黏合屏障市場
    • 加拿大黏合屏障市場
    • 墨西哥黏合劑屏障市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 德國黏合劑屏障市場
    • 法國黏合屏障市場
    • 英國黏合屏障市場
    • 義大利黏合屏障市場
    • 西班牙黏合屏障市場
    • 其他歐洲黏合屏障市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 日本黏合屏障市場
    • 中國阻隔膠市場
    • 澳洲黏合屏障市場
    • 印度膠合劑屏障市場
    • 韓國黏合屏障市場
    • 其他亞太地區黏合劑屏障市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西黏合屏障市場
    • 沙烏地阿拉伯黏合劑屏障市場
    • 南非黏合屏障市場
    • 其他拉丁美洲/中東/非洲黏合屏障市場

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第9章 公司簡介

  • Anika Therapeutics Inc.
  • Baxter International Inc.
  • Leader Biomedical
  • Betatech Medical
  • Fziomed, Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson And Johnson
  • CGBio Inc
  • Atrium Medical Corporation
  • Toray Industries Inc.
簡介目錄
Product Code: A09554

The adhesion barrier market was valued at $0.7 billion in 2023, and is projected to reach $1.5 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.

Adhesion barrier is a medical implant that alleviates the risk of adhesion formation during surgeries. Adhesion is an abnormal connections between tissues or organs that can occur after surgery. Other complications associated with adhesion include bowel obstructions, infertility, and chronic pain, which can arise when tissues stick together while healing. To prevent them from sticking, adhesion barriers create a temporary barrier between the tissues.

The growth of the global adhesion barrier market is driven by alarming rise in the risk of post-surgical adhesions. According to a study, 93% of individuals develop adhesions following one or more abdominal operations. Moreover, increase in awareness among healthcare professionals about the complications associated with adhesions and development of innovative adhesion barrier products notably contribute toward the growth of the global market. Researchers and manufacturers are focusing on the development of adhesion barriers made from bioresorbable materials, which are absorbed by the body gradually, thereby eliminating the need for removal procedures. For instance, Baxter Advanced Surgery, one of the leading providers of healthcare solutions, developed Seprafilm adhesion barrier, which is a sterile, bioresorbable, translucent, and hydrophilic adhesion barrier composed of two anionic polysaccharides, modified sodium hyaluronate and carboxymethylcellulose. This adhesion barrier is capable of significantly reducing the extent, incidence, and severity of adhesions. A randomized, prospective, double-blinded, multicenter clinical study involved 183 patients suffering from ulcerative colitis and familiar polyposis who underwent 2-stage intestinal resection surgery. Among these, 51% of the patients of the Seprafilm Adhesion Barrier group were adhesion-free compared to 6% of control patients post at 8-12 weeks of surgery. Furthermore, increase in reimbursement policies for surgical procedures involving adhesion barriers encourage their use, which boosts the growth of the global market. However, there is no specific adhesion barrier that is widely used to prevent post-surgical adhesions, despite ongoing research, which acts as a key deterrent factor of the market. On the contrary, healthcare professionals are incorporating the use of adhesion barriers into their surgical protocols to minimize the risk of adhesion-related complications, which is expected to drive their demand globally. Moreover, rise in initiatives to spread awareness and establish guidelines regarding the prevention and management of adhesions by medical societies and healthcare organizations is anticipated to offer remunerative opportunities for the expansion of the global market during the forecast period.

The global adhesion barrier market is segmented into type, application, end user, and region. On the basis of type, the market is categorized into synthetic adhesion barrier, and natural adhesion barrier. Depending on application, it is segregated into general/abdominal surgeries, gynecological surgeries, cardiovascular surgeries, orthopedic surgeries, neurological surgeries, and others. By end user, it is fragmented into hospitals, Specialty Clinics, Ambulatory Surgical Centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

  • By product type, the synthetic adhesion barrier segment dominated the market, in terms of share in 2023.
  • Depending on application, the general/abdominal surgeries segment was the major shareholder in 2023.
  • On the basis of end user, the hospital segment acquired the maximum share in 2023.
  • North America holds a significant share of the market.

Competitive Landscape

The competitive analysis and profiles of the major players in the global adhesion barrier market include Anika Therapeutics Inc., Baxter International Inc., leader biomedical, Betatech Medical, Fziomed, Inc., Integra LifeSciences Holdings Corporation, Johnson & Johnson, CGBio Inc., Atrium Medical Corporation, and Toray Industry Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, which strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Market share analysis of players by products/segments
  • Additional country or region analysis- market size and forecast
  • Average Selling Price Analysis / Price Point Analysis
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Type

  • Synthetic Adhesion Barrier
  • Natural Adhesion Barrier

By Application

  • General/Abdominal Surgeries
  • Gynecological Surgeries
  • Cardiovascular Surgeries
  • Orthopedic Surgeries
  • Neurological Surgeries
  • Other Applications

By End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Anika Therapeutics Inc.
    • Baxter International Inc.
    • leader biomedical
    • Betatech Medical
    • fziomed, inc.
    • Integra LifeSciences Holdings Corporation
    • Johnson & Johnson
    • CGBio Inc
    • Atrium Medical Corporation
    • Toray Industries Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ADHESION BARRIER MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Synthetic Adhesion Barrier
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Natural Adhesion Barrier
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: ADHESION BARRIER MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. General/Abdominal Surgeries
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Gynecological Surgeries
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Cardiovascular Surgeries
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Orthopedic Surgeries
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country
  • 5.6. Neurological Surgeries
    • 5.6.1. Key Market Trends, Growth Factors and Opportunities
    • 5.6.2. Market Size and Forecast, By Region
    • 5.6.3. Market Share Analysis, By Country
  • 5.7. Other Applications
    • 5.7.1. Key Market Trends, Growth Factors and Opportunities
    • 5.7.2. Market Size and Forecast, By Region
    • 5.7.3. Market Share Analysis, By Country

CHAPTER 6: ADHESION BARRIER MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Specialty Clinics
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Ambulatory Surgical Centers
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: ADHESION BARRIER MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Adhesion Barrier Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Adhesion Barrier Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Adhesion Barrier Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Adhesion Barrier Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. France Adhesion Barrier Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. UK Adhesion Barrier Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Italy Adhesion Barrier Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. Spain Adhesion Barrier Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Adhesion Barrier Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Adhesion Barrier Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. China Adhesion Barrier Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. Australia Adhesion Barrier Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. India Adhesion Barrier Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. South Korea Adhesion Barrier Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Adhesion Barrier Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Adhesion Barrier Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. Saudi Arabia Adhesion Barrier Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. South Africa Adhesion Barrier Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Adhesion Barrier Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Anika Therapeutics Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Baxter International Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Leader Biomedical
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Betatech Medical
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Fziomed, Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Integra LifeSciences Holdings Corporation
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Johnson And Johnson
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. CGBio Inc
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Atrium Medical Corporation
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Toray Industries Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments